A detailed history of Integral Health Asset Management, LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 100,000 shares of TVTX stock, worth $2.33 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
100,000
Holding current value
$2.33 Million
% of portfolio
0.16%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$13.65 - $19.85 $1.37 Million - $1.99 Million
100,000 New
100,000 $1.74 Million
Q2 2021

Aug 13, 2021

SELL
$14.11 - $26.4 $211,650 - $396,000
-15,000 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$23.37 - $31.77 $350,550 - $476,550
15,000 New
15,000 $375,000

Others Institutions Holding TVTX

About Travere Therapeutics, Inc.


  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.5B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Integral Health Asset Management, LLC Portfolio

Follow Integral Health Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.